Background In this trial of the treatment of newly diagnosed multiple myeloma, we compared
a protocol that entailed a hematopoietic stem-cell autograft followed by an allograft from an …

Significant progress in understanding the mechanisms leading to the development of acute
myeloid leukemia (AML) has led to the identification of numerous molecular abnormalities …

A new hematopoietic cell transplantation–specific comorbidity index (HCT-CI) was effective
in predicting outcomes among patients with hematologic malignancies who underwent HCT …

To prospectively assess the applicability of reduced-intensity conditioning hematopoietic
stem cell transplantation (RIC-HSCT), we wrote a protocol in which all untreated patients 50 …

Most adult patients with acute myeloid leukemia (AML) who reach a complete remission
(CR) after induction chemotherapy will relapse if they do not receive further therapy …

Cytogenetics has an important impact on the prognosis of patients undergoing allogeneic
hematopoietic stem cell transplantation (HSCT) for acute myelogenous leukemia (AML) or …

AML patients with normal karyotype comprise the largest subgroup (∼ 50%) but have a
highly heterogeneous clinical course. By multi-parameter flow cytometry we analyzed CD7 …

We evaluated the efficacy of hematopoietic stem cell transplantation (HSCT) using reduced
intensity (RI) vs. myeloablative (MA) conditioning for patients with acute myeloid leukemia …

Prospective studies are needed to define the place of allogeneic hematopoietic cell
transplantation after nonmyeloablative or reduced-intensity conditioning in patients with …

We conducted a retrospective registry-based analysis to compare the outcome of 361
allogeneic human leukocyte antigen (HLA)-identical peripheral blood stem cell transplants …